In Vitro and In Vivo Effect of pH-Sensitive PLGA-TPGS-Based Hybrid Nanoparticles Loaded with Doxorubicin for Breast Cancer Therapy

• 主要な著者: Renata S. Fernandes (著者), Raquel Gregório Arribada (著者), Juliana O. Silva (著者), Armando Silva-Cunha (著者), Danyelle M. Townsend (著者), Lucas A. M. Ferreira (著者), André L. B. Barros (著者)
• フォーマット: 図書
• 出版事項: MDPI AG, 2022-11-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Doxorubicin (DOX) is an antineoplastic agent clinically employed for treating breast cancer patients. Despite its effectiveness, its inherent adverse toxic side effects often limit its clinical application. To overcome these drawbacks, lipid-polymer hybrid nanoparticles (LPNP) arise as promising nan...